Zonghai LI is the founder of CARsgen Therapeutics. CARsgen Therapeutics has raised $216M in total funding. Latest round: Series C. Based in Shanghai, China.
Zonghai Li is the founder, president, CEO, and CSO of CARsgen Therapeutics, a biotechnology company focused on the innovation and development of chimeric antigen receptor (CAR) T-cell therapeutics. He leads the company's efforts to advance clinical trials and expand manufacturing facilities globally, aiming to launch CARsgen's products for cancer patients worldwide.
Full founder directory · Investor directory · Company funding database · Fundraising library